(CPT) Camden Property Trust - Overview
Sector: Real Estate | Industry: REIT - Residential | Exchange: NYSE (USA) | Market Cap: 10.246m USD | Total Return: -16.1% in 12m
Stock
Apartment Buildings, Property Management, Real Estate Development
Total Rating 29
Risk 55
Buy Signal -0.66
Market Cap:
10,246m
Avg Trading Vol: 96.0M USD
Avg Trading Vol: 96.0M USD
ATR:
2.16%
Peers RS (IBD): 43.3
Peers RS (IBD): 43.3
Risk 5d forecast
Volatility20.4%
Rel. Tail Risk0.20%
Reward TTM
Sharpe Ratio-0.94
Alpha-23.78
Character TTM
Beta0.239
Beta Downside-0.021
Drawdowns 3y
Max DD24.87%
CAGR/Max DD0.08
EPS (Earnings per Share)
EPS CAGR: -71.97%
EPS Trend: -53.4%
EPS Trend: -53.4%
Last SUE: -2.23
Qual. Beats: 0
Qual. Beats: 0
Revenue
Rev. CAGR: 6.25%
Rev. Trend: 68.9%
Rev. Trend: 68.9%
Last SUE: -1.74
Qual. Beats: 0
Qual. Beats: 0
Description: CPT Camden Property Trust
Camden Property Trust (CPT) is a Real Estate Investment Trust (REIT) focused on multifamily apartment communities. REITs are companies that own, operate, or finance income-producing real estate.
The companys operations include ownership, management, development, redevelopment, acquisition, and construction of these properties. As of the provided information, CPT owns and operates 172 properties with 58,759 apartment homes.
With three additional properties under development, CPTs portfolio is projected to expand to 175 properties and 59,921 apartment homes. This growth strategy is common among REITs seeking to increase their asset base and rental income.
Investors can find more detailed financial analysis and historical data on ValueRay.
- Rent growth in Sunbelt markets boosts revenue
- Interest rate hikes increase borrowing costs
- Apartment occupancy rates impact rental income
- Construction costs affect development profitability
- Property tax increases reduce net operating income
Piotroski VR‑10 (Strict, 0-10)
6.0
| Net Income: 384.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 4.82 > 1.0 |
| NWC/Revenue: -26.01% < 20% (prev -23.71%; Δ -2.30% < -1%) |
| CFO/TA 0.09 > 3% & CFO 826.6m > Net Income 384.5m |
| Net Debt (3.88b) to EBITDA (1.15b): 3.38 < 3 |
| Current Ratio: 0.10 > 1.5 & < 3 |
| Outstanding Shares: last quarter (108.6m) vs 12m ago 0.09% < -2% |
| Gross Margin: 61.41% > 18% (prev 0.61%; Δ 6.08k% > 0.5%) |
| Asset Turnover: 17.59% > 50% (prev 17.44%; Δ 0.15% > 0%) |
| Interest Coverage Ratio: 3.89 > 6 (EBITDA TTM 1.15b / Interest Expense TTM 138.2m) |
Altman Z''
-0.46
| A: -0.05 (Total Current Assets 46.1m - Total Current Liabilities 455.4m) / Total Assets 9.04b |
| B: -0.11 (Retained Earnings -969.2m / Total Assets 9.04b) |
| C: 0.06 (EBIT TTM 537.2m / Avg Total Assets 8.95b) |
| D: -0.21 (Book Value of Equity -965.9m / Total Liabilities 4.60b) |
| Altman-Z'' Score: -0.46 = B |
Beneish M
-2.98
| DSRI: 0.97 (Receivables 8.88m/8.99m, Revenue 1.57b/1.54b) |
| GMI: 1.00 (GM 61.41% / 61.18%) |
| AQI: 1.19 (AQ_t 0.03 / AQ_t-1 0.03) |
| SGI: 1.02 (Revenue 1.57b / 1.54b) |
| TATA: -0.05 (NI 384.5m - CFO 826.6m) / TA 9.04b) |
| Beneish M-Score: -2.98 (Cap -4..+1) = A |
What is the price of CPT shares?
As of April 02, 2026, the stock is trading at USD 97.66 with a total of 1,218,573 shares traded.
Over the past week, the price has changed by +2.06%, over one month by -9.09%, over three months by -9.82% and over the past year by -16.10%.
Over the past week, the price has changed by +2.06%, over one month by -9.09%, over three months by -9.82% and over the past year by -16.10%.
Is CPT a buy, sell or hold?
Camden Property Trust has received a consensus analysts rating of 3.68.
Therefor, it is recommend to hold CPT.
- StrongBuy: 8
- Buy: 2
- Hold: 14
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the CPT price?
| ISSUER | TARGET | UP/DOWN |
|---|---|---|
| Wallstreet Target Price | 115.2 | 18% |
| Analysts Target Price | 115.2 | 18% |
CPT Fundamental Data Overview
as of 01 April 2026
P/E Trailing = 27.6384 P/E Forward = 69.4444
P/S = 6.4574
P/B = 2.3078
P/EG = 9.1681
Revenue TTM = 1.57b USD
EBIT TTM = 537.2m USD
EBITDA TTM = 1.15b USD
Long Term Debt = 3.90b USD (from longTermDebt, last quarter)
Short Term Debt = 1.16b USD (from shortTermDebt, last quarter)
Debt = 3.90b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.88b USD (from netDebt column, last quarter)
Enterprise Value = 14.12b USD (10.25b + Debt 3.90b - CCE 25.2m)
Interest Coverage Ratio = 3.89 (Ebit TTM 537.2m / Interest Expense TTM 138.2m)
EV/FCF = 17.10x (Enterprise Value 14.12b / FCF TTM 825.6m)
FCF Yield = 5.85% (FCF TTM 825.6m / Enterprise Value 14.12b)
FCF Margin = 52.47% (FCF TTM 825.6m / Revenue TTM 1.57b)
Net Margin = 24.43% (Net Income TTM 384.5m / Revenue TTM 1.57b)
Gross Margin = 61.41% ((Revenue TTM 1.57b - Cost of Revenue TTM 607.2m) / Revenue TTM)
Gross Margin QoQ = 62.20% (prev 60.69%)
Tobins Q-Ratio = 1.56 (Enterprise Value 14.12b / Total Assets 9.04b)
Interest Expense / Debt = 0.87% (Interest Expense 34.1m / Debt 3.90b)
Taxrate = 0.91% (1.45m / 159.4m)
NOPAT = 532.3m (EBIT 537.2m * (1 - 0.91%))
Current Ratio = 0.10 (Total Current Assets 46.1m / Total Current Liabilities 455.4m)
Debt / Equity = 0.89 (Debt 3.90b / totalStockholderEquity, last quarter 4.36b)
Debt / EBITDA = 3.38 (Net Debt 3.88b / EBITDA 1.15b)
Debt / FCF = 4.69 (Net Debt 3.88b / FCF TTM 825.6m)
Total Stockholder Equity = 4.53b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.30% (Net Income 384.5m / Total Assets 9.04b)
RoE = 8.50% (Net Income TTM 384.5m / Total Stockholder Equity 4.53b)
RoCE = 6.37% (EBIT 537.2m / Capital Employed (Equity 4.53b + L.T.Debt 3.90b))
RoIC = 6.39% (NOPAT 532.3m / Invested Capital 8.33b)
WACC = 5.18% (E(10.25b)/V(14.15b) * Re(6.82%) + D(3.90b)/V(14.15b) * Rd(0.87%) * (1-Tc(0.01)))
Discount Rate = 6.82% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -33.33 | Cagr: -0.77%
[DCF] Terminal Value 88.36% ; FCFF base≈647.8m ; Y1≈792.1m ; Y5≈1.32b
[DCF] Fair Price = 330.1 (EV 38.44b - Net Debt 3.88b = Equity 34.57b / Shares 104.7m; r=6.0% [WACC]; 5y FCF grow 23.81% → 3.0% )
EPS Correlation: -53.38 | EPS CAGR: -71.97% | SUE: -2.23 | # QB: 0
Revenue Correlation: 68.87 | Revenue CAGR: 6.25% | SUE: -1.74 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.33 | Chg7d=+0.325 | Chg30d=+0.005 | Revisions Net=+1 | Analysts=2
EPS current Year (2026-12-31): EPS=1.29 | Chg7d=+0.184 | Chg30d=+0.047 | Revisions Net=+1 | Growth EPS=+1.0% | Growth Revenue=-0.8%
EPS next Year (2027-12-31): EPS=1.75 | Chg7d=+0.001 | Chg30d=-0.224 | Revisions Net=+1 | Growth EPS=+34.9% | Growth Revenue=+2.9%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.3% (Discount Rate 7.9% - Earnings Yield 3.6%)
[Growth] Growth Spread = -5.7% (Analyst -1.4% - Implied 4.3%)